Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease

GeroScience(2024)10.1007/s11357-024-01116-0Source: DataRank Database

DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease is a research paper published in GeroScience (2024). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: hybridTopics (41)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Yun Wang ORCID,Hui Shen ORCID,Eun-Kyung Bae ORCID,Yazhou Li ORCID,Kumar Sambamurti ORCID

Live enrichment

PubMed:38563864 PMC:PMC11336009

Michael J. Fox Foundation for Parkinson's Research

Grant: NHG

National Institute on Aging

Grant: Intramural Research Program AG000333

National Health Research Institutes, Taiwan

Grant: Intramural Research Grant

Ministry of Science and Technology, Taiwan

Grant: MOST-110-2320-B-400-007

Ministry of Science and Technology, Taiwan

Grant: MOST-111-2320-B-400-010

National Institutes of Health

Grant: 1ZIAAG000333-15

Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)

hybridLicense: cc-by

publisherhttps://link.springer.com/content/pdf/10.1007/s11357-024-01116-0.pdf

publisherhttps://link.springer.com/article/10.1007/s11357-024-01116-0/fulltext.html

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11336009/pdf/11357_2024_Article_1116.pdf

Europe_PMChttps://europepmc.org/articles/PMC11336009

Europe_PMChttps://europepmc.org/articles/PMC11336009?pdf=render

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsHumansRatsRats, Sprague-DawleyParkinsonian DisordersDisease Models, AnimalOxidopamineMaleIncretinsDipeptidyl-Peptidase IV InhibitorsDopaminergic NeuronsSitagliptin PhosphateNeuroinflammatory Diseases

Keywords

DopamineNeurogenesisNeurodegeneration6-hydroxydopamineGIPneuroinflammationParkinson’s DiseaseSitagliptinGliptinsIncretins, Glp-1Pf-00734,200MaleDipeptidyl-Peptidase IV InhibitorsDopaminergic NeuronsSitagliptin PhosphateIncretinsRatsRats, Sprague-DawleyDisease Models, AnimalParkinsonian DisordersNeuroinflammatory DiseasesAnimalsHumansOriginal ArticleOxidopamine